These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 26018159)

  • 1. Vaccine-Induced Linear Epitope-Specific Antibodies to Simian Immunodeficiency Virus SIVmac239 Envelope Are Distinct from Those Induced to the Human Immunodeficiency Virus Type 1 Envelope in Nonhuman Primates.
    Shen X; Duffy R; Howington R; Cope A; Sadagopal S; Park H; Pal R; Kwa S; Ding S; Yang OO; Fouda GG; Le Grand R; Bolton D; Esteban M; Phogat S; Roederer M; Amara RR; Picker LJ; Seder RA; McElrath MJ; Barnett S; Permar SR; Shattock R; DeVico AL; Felber BK; Pavlakis GN; Pantaleo G; Korber BT; Montefiori DC; Tomaras GD
    J Virol; 2015 Aug; 89(16):8643-50. PubMed ID: 26018159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predominant envelope variable loop 2-specific and gp120-specific antibody-dependent cellular cytotoxicity antibody responses in acutely SIV-infected African green monkeys.
    Nguyen QN; Martinez DR; Himes JE; Whitney Edwards R; Han Q; Kumar A; Mangan R; Nicely NI; Xie G; Vandergrift N; Shen X; Pollara J; Permar SR
    Retrovirology; 2018 Mar; 15(1):24. PubMed ID: 29523166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid Development of gp120-Focused Neutralizing B Cell Responses during Acute Simian Immunodeficiency Virus Infection of African Green Monkeys.
    Amos JD; Himes JE; Armand L; Gurley TC; Martinez DR; Colvin L; Beck K; Overman RG; Liao HX; Moody MA; Permar SR
    J Virol; 2015 Sep; 89(18):9485-98. PubMed ID: 26157116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assorted mutations in the envelope gene of simian immunodeficiency virus lead to loss of neutralization resistance against antibodies representing a broad spectrum of specificities.
    Johnson WE; Sanford H; Schwall L; Burton DR; Parren PW; Robinson JE; Desrosiers RC
    J Virol; 2003 Sep; 77(18):9993-10003. PubMed ID: 12941910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of serum antibody reactivities to a conformational and to linear antigenic sites in the external envelope glycoprotein of simian immunodeficiency virus (SIVmac) induced by infection and vaccination.
    McBride BW; Corthals G; Rud E; Kent K; Webster S; Cook N; Cranage MP
    J Gen Virol; 1993 Jun; 74 ( Pt 6)():1033-41. PubMed ID: 7685372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breakthrough Virus Neutralization Resistance as a Correlate of Protection in a Nonhuman Primate Heterologous Simian Immunodeficiency Virus Vaccine Challenge Study.
    Lee FH; Mason R; Welles H; Learn GH; Keele BF; Roederer M; Bar KJ
    J Virol; 2015 Dec; 89(24):12388-400. PubMed ID: 26423953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo induction of cellular and humoral immune responses by hybrid DNA vectors encoding simian/human immunodeficiency virus/hepatitis B surface antigen virus particles in BALB/c and HLA-A2-transgenic mice.
    Marsac D; Puaux AL; Rivière Y; Michel ML
    Immunobiology; 2005; 210(5):305-19. PubMed ID: 16164038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bovine alpha-2-HS-glycoprotein functions as a booster antigen for efficiently stimulating humoral immune responses to CCR5 and SIVmac239 envelope glycoprotein.
    Otsubo Y; Yashiro S; Nozaki K; Matsuura K; Kiyonaga K; Mitsumata R; Takahashi Y; Masuyama M; Muneoka A; Takamune N; Shoji S; Misumi S
    Biochem Biophys Res Commun; 2014 Jan; 443(1):301-7. PubMed ID: 24309114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody responses elicited in macaques immunized with human immunodeficiency virus type 1 (HIV-1) SF162-derived gp140 envelope immunogens: comparison with those elicited during homologous simian/human immunodeficiency virus SHIVSF162P4 and heterologous HIV-1 infection.
    Derby NR; Kraft Z; Kan E; Crooks ET; Barnett SW; Srivastava IK; Binley JM; Stamatatos L
    J Virol; 2006 Sep; 80(17):8745-62. PubMed ID: 16912322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic rates of antibody binding correlate with neutralization sensitivity of variant simian immunodeficiency virus strains.
    Steckbeck JD; Orlov I; Chow A; Grieser H; Miller K; Bruno J; Robinson JE; Montelaro RC; Cole KS
    J Virol; 2005 Oct; 79(19):12311-20. PubMed ID: 16160158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutralizing monoclonal antibody against a external envelope glycoprotein (gp110) of SIVmac251.
    Matsumi S; Matsushita S; Yoshimura K; Javaherian K; Takatsuki K
    AIDS Res Hum Retroviruses; 1995 Apr; 11(4):501-8. PubMed ID: 7632464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of four antibody-binding sites in the envelope proteins of simian immunodeficiency virus, SIVsm.
    Samuelsson A; Björling E; Putkonen P; Utter G; Chiodi F; Norrby E
    AIDS; 1993 Feb; 7(2):159-65. PubMed ID: 7682082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Common themes of antibody maturation to simian immunodeficiency virus, simian-human immunodeficiency virus, and human immunodeficiency virus type 1 infections.
    Cole KS; Murphey-Corb M; Narayan O; Joag SV; Shaw GM; Montelaro RC
    J Virol; 1998 Oct; 72(10):7852-9. PubMed ID: 9733822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ability of the V3 loop of simian immunodeficiency virus to serve as a target for antibody-mediated neutralization: correlation of neutralization sensitivity, growth in macrophages, and decreased dependence on CD4.
    Means RE; Matthews T; Hoxie JA; Malim MH; Kodama T; Desrosiers RC
    J Virol; 2001 Apr; 75(8):3903-15. PubMed ID: 11264379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SIV neutralization epitopes.
    Javaherian K; Langlois AJ; LaRosa GJ
    Chem Immunol; 1993; 56():78-90. PubMed ID: 7680868
    [No Abstract]   [Full Text] [Related]  

  • 16. Characterization of monoclonal antibodies to the envelope proteins of an immunodeficiency virus of African green monkeys, SIVagmTYO-7.
    Otteken A; Nick S; Bergter W; Lüke W; Stahl-Hennig C; Peters JH; Voss G; Hunsmann G
    J Med Primatol; 1993 Jun; 22(4):263-8. PubMed ID: 7693947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of envelope glycoprotein-specific antibodies from SIV-infected and gp110-immunized monkeys in ACC and ADCC assays.
    Ohkawa S; Xu K; Wilson LA; Montelaro R; Martin LN; Murphey-Corb M
    AIDS Res Hum Retroviruses; 1995 Mar; 11(3):395-403. PubMed ID: 7786584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human immunodeficiency virus type 1 envelope glycoprotein-specific cytotoxic T lymphocytes in simian-human immunodeficiency virus-infected rhesus monkeys.
    Voss G; Li J; Manson K; Wyand M; Sodroski J; Letvin NL
    Virology; 1995 Apr; 208(2):770-5. PubMed ID: 7747449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An HIV-1 infection-related idiotype/clonotype (1F7) is expressed on antibodies directed to envelope glycoprotein in simian immunodeficiency virus- and chimeric simian/human immunodeficiency virus-infected rhesus monkeys.
    Müller S; Margolin DH; Min G
    Hybridoma; 1997 Feb; 16(1):17-21. PubMed ID: 9085123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic neutralization of a chimeric SIV/HIV type 1 virus with combinations of human anti-HIV type 1 envelope monoclonal antibodies or hyperimmune globulins.
    Li A; Baba TW; Sodroski J; Zolla-Pazner S; Gorny MK; Robinson J; Posner MR; Katinger H; Barbas CF; Burton DR; Chou TC; Ruprecht RM
    AIDS Res Hum Retroviruses; 1997 May; 13(8):647-56. PubMed ID: 9168233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.